Education
About Us
Working with TipRanks
Follow Us
Azenta (AZTA)
NASDAQ:AZTA
AZTA Stock Chart & Stats
$28.49
-$0.47(-0.91%)
At close: 4:00 PM EST
$28.49
-$0.47(-0.91%)
Day’s Range― - ―
52-Week Range$23.91 - $55.64
Previous CloseN/A
Volume88.55K
Average Volume (3M)510.09K
Market Cap
$1.31B
Enterprise Value$1.05B
Total Cash (Recent Filing)$409.66M
Total Debt (Recent Filing)$54.46M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
May 11, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding45,989,580
10 Day Avg. Volume696,547
30 Day Avg. Volume510,090
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)0.76
Price to Sales (P/S)2.21
P/FCF Ratio34.28
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue1.77
Enterprise Value/Gross Profit3.97
Enterprise Value/Ebitda33.38
Forecast
1Y Price Target
$39.50Price Target Upside38.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Long-range Plan And Capital FlexibilityManagement's long-range plan with FY28 targets plus increasing balance-sheet optionality boosts the company's ability to execute strategic investments, divestitures or capital-return actions that could enhance shareholder value.
Product And Regional GrowthStrength in next-generation sequencing, gene synthesis and biorepository services, combined with notable China and international revenue growth, supports a more diversified revenue mix and potential top-line acceleration.
Restructuring And Margin ExpansionOngoing restructuring and regionalization of the multiomics business are expected to drive margin expansion and help return the segment to growth, supporting higher adjusted EBITDA in FY26.
Bears Say
Bookings And Capex SlowdownA challenged capital environment and government-related disruptions have slowed bookings and deferred equipment purchases, shifting expected sales and margin improvements toward the back half of the year.
Margin Pressure From CostsLower gross margins coupled with elevated operating costs have resulted in earnings misses and could continue to pressure profitability if cost trends are not corrected.
Product Quality And Rework CostsPersistent quality issues in later-stage automated stores projects have increased rework and remediation expenses, creating a drag on margins and delaying project deliveries.
Azenta News
AZTA FAQ
What was Azenta’s price range in the past 12 months?
Azenta lowest stock price was $23.91 and its highest was $55.63 in the past 12 months.
What is Azenta’s market cap?
Azenta’s market cap is $1.31B.
When is Azenta’s upcoming earnings report date?
Azenta’s upcoming earnings report date is May 11, 2026 which is in 94 days.
How were Azenta’s earnings last quarter?
Azenta released its earnings results on Feb 04, 2026. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.138 by -$0.048.
Is Azenta overvalued?
According to Wall Street analysts Azenta’s price is currently Undervalued.
Does Azenta pay dividends?
Azenta pays a Quarterly dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Azenta dividends here
What is Azenta’s EPS estimate?
Azenta’s EPS estimate is 0.12.
How many shares outstanding does Azenta have?
Azenta has 45,989,580 shares outstanding.
What happened to Azenta’s price movement after its last earnings report?
Azenta reported an EPS of $0.09 in its last earnings report, missing expectations of $0.138. Following the earnings report the stock price went down -22.812%.
Which hedge fund is a major shareholder of Azenta?
Currently, no hedge funds are holding shares in AZTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Azenta Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$39.50 (38.65% Upside)
$39.50 (38.65% Upside)
Blogger Sentiment
Bullish
AZTA Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 397.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 6.2%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
News Sentiment
Bullish
Bullish news 71%
Bearish news 29%
Bearish news 29%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.14%
12-Months-Change
Fundamentals
Return on Equity
1.41%
Trailing 12-Months
Asset Growth
-1.93%
Trailing 12-Months
Company Description
Azenta
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
AZTA Company Deck
AZTA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: management reaffirmed full-year guidance, highlighted strong cash, active capital allocation (including a $250M buyback authorization), and clear operational initiatives (ABS, Kaizen, regionalization) that support a planned margin and revenue ramp in the back half. However, near-term results show meaningful margin compression (gross margin down ~360 bps, adjusted EBITDA margin down ~230 bps), automated store quality remediation costs ($3M–$5M), North American softness and a meaningful decline in Sanger sequencing. Given the mix of strategic positives and notable near-term headwinds, the tone is cautiously optimistic but tempered by execution and macro risks.View all AZTA earnings summariesAZTA Stock 12 Month Forecast
Average Price Target
$39.50
▲(38.65% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---